These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28654940)

  • 41. Investigating Acoustic Correlates of Intelligibility Gains and Losses During Slowed Speech: A Hybridization Approach.
    van Brenk F; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1343-1360. PubMed ID: 34048663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Intelligibility Measures for Adults With Parkinson's Disease, Adults With Multiple Sclerosis, and Healthy Controls.
    Stipancic KL; Tjaden K; Wilding G
    J Speech Lang Hear Res; 2016 Apr; 59(2):230-8. PubMed ID: 26556727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effects of Intensive Voice Treatment in Mandarin Speakers With Parkinson's Disease: Acoustic and Perceptual Findings.
    Hsu SC; Jiao Y; Berisha V; McAuliffe MJ; Lin P; Wu RM; Cheng SJ; Levy ES
    Am J Speech Lang Pathol; 2022 May; 31(3):1354-1367. PubMed ID: 35394803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lexical Characteristics of the Speech Intelligibility Test: Effects on Transcription Intelligibility for Speakers With Multiple Sclerosis and Parkinson's Disease.
    Stipancic KL; Wilding G; Tjaden K
    J Speech Lang Hear Res; 2023 Aug; 66(8S):3115-3131. PubMed ID: 36931064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of face masks on spectral acoustics of speech: Effect of clear and loud speech styles.
    Knowles T; Badh G
    J Acoust Soc Am; 2022 May; 151(5):3359. PubMed ID: 35649889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Speech Versus Speaking: The Experiences of People With Parkinson's Disease and Implications for Intervention.
    Yorkston K; Baylor C; Britton D
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):561-568. PubMed ID: 28654939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of Loud Voice and Clear Speech on the Use of Vocal Fry in Women.
    Behrman A; Akhund A
    Folia Phoniatr Logop; 2016; 68(4):159-166. PubMed ID: 28118633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria.
    Hammen VL; Yorkston KM; Minifie FD
    J Speech Hear Res; 1994 Apr; 37(2):244-53. PubMed ID: 8028306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement effects of clear speech and word-initial position in Korean glides.
    Chang SE
    J Acoust Soc Am; 2017 Jun; 141(6):4188. PubMed ID: 28618810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acoustic Predictors of Ease of Understanding in Spanish Speakers With Dysarthria Associated With Parkinson's Disease.
    Moya-Galé G; Wisler AA; Walsh SJ; McAuliffe MJ; Levy ES
    J Speech Lang Hear Res; 2023 Aug; 66(8S):2999-3012. PubMed ID: 36508721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship Between F2 Slope and Intelligibility in Parkinson's Disease: Lexical Effects and Listening Environment.
    Chiu YF; Forrest K; Loux T
    Am J Speech Lang Pathol; 2019 Jul; 28(2S):887-894. PubMed ID: 31306601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acoustic and perceptual speech characteristics of native Mandarin speakers with Parkinson's disease.
    Hsu SC; Jiao Y; McAuliffe MJ; Berisha V; Wu RM; Levy ES
    J Acoust Soc Am; 2017 Mar; 141(3):EL293. PubMed ID: 28372040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
    Sauvageau VM; Roy JP; Langlois M; Macoir J
    Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative assessment of interutterance stability: application to dysarthria.
    Cummins F; Lowit A; van Brenk F
    J Speech Lang Hear Res; 2014 Feb; 57(1):81-9. PubMed ID: 24687469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting Intelligibility Gains in Dysarthria Through Automated Speech Feature Analysis.
    Fletcher AR; Wisler AA; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3058-3068. PubMed ID: 29075755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.